155 related articles for article (PubMed ID: 10928048)
21. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
22. E-cadherin expression correlates with tumor differentiation in colorectal cancer.
Karatzas G; Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Riza F; Papanikolaou D
Hepatogastroenterology; 1999; 46(25):232-5. PubMed ID: 10228798
[TBL] [Abstract][Full Text] [Related]
23. Expression of vascular endothelial growth factor and the adhesion molecule E-cadherin in non-small cell lung cancer.
Stefanou D; Goussia AC; Arkoumani E; Agnantis NJ
Anticancer Res; 2003; 23(6C):4715-20. PubMed ID: 14981918
[TBL] [Abstract][Full Text] [Related]
24. [Expression of E-cadherin gene protein in oral verrucous carcinoma].
Tang ZG; Zou P; Xie XL
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):206-8. PubMed ID: 14653067
[TBL] [Abstract][Full Text] [Related]
25. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer.
Musiał J; Sporny S; Nowicki A
Pol J Pathol; 2007; 58(4):235-43. PubMed ID: 18459457
[TBL] [Abstract][Full Text] [Related]
27. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium.
Kato Y; Hirano T; Yoshida K; Yashima K; Akimoto S; Tsuji K; Ohira T; Tsuboi M; Ikeda N; Ebihara Y; Kato H
Lung Cancer; 2005 Jun; 48(3):323-30. PubMed ID: 15893000
[TBL] [Abstract][Full Text] [Related]
28. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China.
Chen XF; Zhang HT; Qi QY; Sun MM; Tao LY
Lung Cancer; 2005 Apr; 48(1):69-76. PubMed ID: 15777972
[TBL] [Abstract][Full Text] [Related]
29. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
Plzák J; Smetana K; Hrdlicková E; Kodet R; Holíková Z; Liu FT; Dvoránkova B; Kaltner H; Betka J; Gabius HJ
Int J Oncol; 2001 Jul; 19(1):59-64. PubMed ID: 11408923
[TBL] [Abstract][Full Text] [Related]
30. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions.
Chiles MC; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Oct; 16(10):1014-8. PubMed ID: 14559984
[TBL] [Abstract][Full Text] [Related]
31. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
Chen Q; Lipkina G; Song Q; Kramer RH
Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
[TBL] [Abstract][Full Text] [Related]
32. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma.
Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
Oral Oncol; 2006 Feb; 42(2):190-200. PubMed ID: 16249116
[TBL] [Abstract][Full Text] [Related]
33. E-cadherin expression in primary carcinomas of the breast and its distant metastases.
Kowalski PJ; Rubin MA; Kleer CG
Breast Cancer Res; 2003; 5(6):R217-22. PubMed ID: 14580257
[TBL] [Abstract][Full Text] [Related]
34. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.
Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP
Cancer Res; 2007 Aug; 67(16):7654-64. PubMed ID: 17699770
[TBL] [Abstract][Full Text] [Related]
35. Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours.
Fuller LC; Allen MH; Montesu M; Barker JN; Macdonald DM
Br J Dermatol; 1996 Jan; 134(1):28-32. PubMed ID: 8745882
[TBL] [Abstract][Full Text] [Related]
36. Chemopreventive alteration of the cell-cell adhesion in head and neck squamous cell cancer.
Naim R; Chang RC; Schultz J; Hormann K
Oncol Rep; 2006 Aug; 16(2):273-7. PubMed ID: 16820902
[TBL] [Abstract][Full Text] [Related]
37. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
[TBL] [Abstract][Full Text] [Related]
38. E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions.
Hubert P; Caberg JH; Gilles C; Bousarghin L; Franzen-Detrooz E; Boniver J; Delvenne P
J Pathol; 2005 Jul; 206(3):346-55. PubMed ID: 15852499
[TBL] [Abstract][Full Text] [Related]
39. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
[TBL] [Abstract][Full Text] [Related]
40. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]